A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 and Humalog Across Different Subcutaneous Doses in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 20 Oct 2017 Planned End Date changed from 1 Mar 2018 to 1 Feb 2018.
- 20 Oct 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Feb 2018.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.